Hypersexuality during treatment with cariprazine in a patient with schizophrenia? A case report

[1] Jauhar S(2022)Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders Schizophrenia Lancet 399 473-486

[2] Johnstone M(2022)Dosing cariprazine within and beyond clinical trials: recommendations for the treatment of schizophrenia Front Psych 12 801641-111

[3] McKenna PJ(2022)Do cariprazine and brexpiprazole cause impulse control symptoms? A case/noncase study Front Psych 5 770234-985

[4] Kehr J(2021)Novel antipsychotics specificity profile: a clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone Eur Neuropsychopharmacol 1 107-167

[5] Wang FH(2019)Functional and symptomatic improvement with cariprazine in various psychiatric patients: a case series Eur Neuropsychopharmacol 29 971-45

[6] Ichinose F(2022)Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Front Psych 1 1401-163

[7] Yoshitake S(2023)Sexuelle Enthemmung bei Therapie mit Aripiprazol [Hypersexuality Induced by Aripiprazole] Psychiatry Clin Neurosci 77 160-59

[8] Farkas B(2020)Aripiprazole induced hypersexuality, when we should be cautious? Psychiatr Prax. 47 43-1350

[9] Kiss B(2017)Aripiprazole and impulse-control disorders: a recent FDA warning and a case report Asian J Psychiatr 29 162-24

[10] Adham N(2017)Hypersexuality induced by Aripiprazole: two case reports and review of the literature Prim Care Companion CNS Disord 19 26647-73

[1] Jauhar S(2022)Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders Schizophrenia Lancet 399 473-486

[2] Johnstone M(2022)Dosing cariprazine within and beyond clinical trials: recommendations for the treatment of schizophrenia Front Psych 12 801641-111

[3] McKenna PJ(2022)Do cariprazine and brexpiprazole cause impulse control symptoms? A case/noncase study Front Psych 5 770234-985

[4] Kehr J(2021)Novel antipsychotics specificity profile: a clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone Eur Neuropsychopharmacol 1 107-167

[5] Wang FH(2019)Functional and symptomatic improvement with cariprazine in various psychiatric patients: a case series Eur Neuropsychopharmacol 29 971-45

[6] Ichinose F(2022)Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Front Psych 1 1401-163

[7] Yoshitake S(2023)Sexuelle Enthemmung bei Therapie mit Aripiprazol [Hypersexuality Induced by Aripiprazole] Psychiatry Clin Neurosci 77 160-59

[8] Farkas B(2020)Aripiprazole induced hypersexuality, when we should be cautious? Psychiatr Prax. 47 43-1350

[9] Kiss B(2017)Aripiprazole and impulse-control disorders: a recent FDA warning and a case report Asian J Psychiatr 29 162-24

[10] Adham N(2017)Hypersexuality induced by Aripiprazole: two case reports and review of the literature Prim Care Companion CNS Disord 19 26647-73